Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Giacomo, Bregni"'
Autor:
Pashalina Kehagias, Nadège Kindt, Mohammad Krayem, Ahmad Najem, Giulia Agostini, Elena Acedo Reina, Giacomo Bregni, Francesco Sclafani, Fabrice Journe, Ahmad Awada, Ghanem E. Ghanem, Alain Hendlisz
Publikováno v:
Cells, Vol 11, Iss 22, p 3663 (2022)
Potential intrinsic resistance mechanisms to regorafenib were explored after short exposure (3 days) on five CRC cell lines (HCT-116, SW1116, LS-1034, SW480, Caco-2). The observation of senescence-like features led to the investigation of a drug-init
Externí odkaz:
https://doaj.org/article/f8491e9a6d53466e892ad25bf87c4af1
Autor:
Giacomo Bregni, Elena Trevisi, Rita Saúde Conde, Michele Vanhooren, Tugba Akin Telli, Irene Assaf, Alain Hendlisz, Massimo Di Maio, Francesco Sclafani
Publikováno v:
JNCI: Journal of the National Cancer Institute. 115:505-513
Background A minority of phase III trials in gastrointestinal oncology are positive. We assessed the association between their outcome and the level and characteristics of preexisting evidence. Methods EMBASE, PubMed, and proceedings from internation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38804d786e6724c169f3520f98f8fd99
https://doi.org/10.1093/jnci/djad030
https://doi.org/10.1093/jnci/djad030
Autor:
Zelda, Paquier, Shih-Li, Chao, Giacomo, Bregni, Ana Veron, Sanchez, Thomas, Guiot, Jennifer, Dhont, Akos, Gulyban, Hugo, Levillain, Francesco, Sclafani, Nick, Reynaert, Maria Antonietta, Bali
Publikováno v:
Physica Medica. 103:138-146
The aim of this study was to perform a quantitative quality assurance of diffusion-weighted MRI to assess the variability of the mean apparent diffusion coefficient (ADC) and other radiomic features across the scanners involved in the REGINA trial.Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d1d1a8b309485f5fba51eaef2db40ec
https://doi.org/10.1016/j.ejmp.2022.10.009
https://doi.org/10.1016/j.ejmp.2022.10.009
Publikováno v:
Current Opinion in Oncology. 34:382-388
In this article, we briefly summarise the current knowledge about human epidermal growth factor receptor 2 (HER2) alterations in colorectal cancer (CRC) and provide an overview of the latest published evidence especially regarding standardisation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8d01ad6b75657c139b5d15d7cc46e45
https://doi.org/10.1097/cco.0000000000000842
https://doi.org/10.1097/cco.0000000000000842
Autor:
Claudia Cardone, Vincenzo Sforza, Antonio Avallone, Anna Nappi, Vincenzo Montesarchio, Francesca Andreozzi, Maria Biglietto, Filomena Calabrese, Roberto Bordonaro, Stefano Cordio, Giacomo Bregni, Antonio Febbraro, Rocio Garcia-Carbonero, Jaime Feliu
Publikováno v:
ESMO Open, Vol 4, Iss 4 (2019)
Background In patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC), the role of maintenance therapy after first-line treatment with chemotherapy plus antiepidermal growth factor receptor (EGFR) monoclonal antibodies (MoAb) is still an
Externí odkaz:
https://doaj.org/article/25737148f9664ae5b938984e5084ce09
Publikováno v:
Current Opinion in Oncology. 33:372-377
Purpose of review To summarize current standards of care, discuss results of recent studies and present ongoing clinical trials for anal squamous cell carcinoma (ASCC). Recent findings Over the last year, no practice changing studies have been report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dea0194d1fdc92866c11c351f757ceb5
https://doi.org/10.1097/cco.0000000000000748
https://doi.org/10.1097/cco.0000000000000748
Autor:
Francesca Bergamo, Roberto Labianca, Tosca Investigators, Maria Giulia Zampino, Anna Maria Bochicchio, Francesca Galli, Fabrizio Artioli, Monica Ronzoni, Giovanni Gerardo Cardellino, Domenico Bilancia, Maurizio Cantore, Maria Di Bartolomeo, Domenico Corsi, Lorenza Rimassa, Maria Banzi, F. Galli, Eliana Rulli, Giacomo Bregni, Gerardo Rosati, Stefano Tamberi, Rodolfo Mattioli, Paolo Marchetti
Publikováno v:
Oncologist
Background Although American Society of Clinical Oncology and European Society for Medical Oncology guidelines have identified the negative prognostic factors that clinicians have to consider when treating their patients with stage II colon cancer (C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50d5a60993eb47d0e1a8ea69465aba02
https://doi.org/10.1634/theoncologist.2019-0736
https://doi.org/10.1634/theoncologist.2019-0736
Autor:
Francesco Sclafani, Giacomo Bregni, Amélie Deleporte, Tugba Akin Telli, Alain Hendlisz, Silvia Camera
Publikováno v:
Cancer Letters. 469:142-150
Oesophago-gastric cancers (OGCs) are aggressive tumours. While better peri-operative strategies, increased number of cytotoxic agents and availability of targeted therapies have improved survival, there remains an unmet need for novel treatment appro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b60f7429d7e9222b3223818d633eeefd
https://doi.org/10.1016/j.canlet.2019.10.036
https://doi.org/10.1016/j.canlet.2019.10.036
Autor:
Giacomo Bregni, Benjamin Beck
Publikováno v:
Cancers. 14(6)
Oesophageal cancer is one of the leading causes of cancer-related death worldwide. Oesophageal cancer occurs as squamous cell carcinoma (ESCC) or adenocarcinoma (EAC). Prognosis for patients with either ESCC or EAC is poor, with less than 20% of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a67c988a80085998623bd5f7eb1441ed
https://pubmed.ncbi.nlm.nih.gov/35326673
https://pubmed.ncbi.nlm.nih.gov/35326673
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e3fc80ac503504a6d2ded5c8a089e42
https://pubmed.ncbi.nlm.nih.gov/35025609
https://pubmed.ncbi.nlm.nih.gov/35025609